ADAPTIMMUNE THERAPEUTICS PLC |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.15 USD | -1.71% |
|
+4.55% | +45.02% |
Chart calendar Adaptimmune Therapeutics plc
b45ba37204.yX6hxiGfN1QcwxLHzlzUIs1IpcmgTOCqI3uI5wrKGUI.mFPCtRXdBzhwjGuypBO6Frcb-v3vKKWcYA3MvVuAcDamDPCWcvl1Y2q3YQ~b41c0068fd4defb64263bdba72cf8517
Upcoming events on Adaptimmune Therapeutics plc
Past events on Adaptimmune Therapeutics plc
| Today | EF Hutton Investor Conference |
| Today | Q1 2024 Earnings Release Pre-market |
| 2024-05-14 07:00 am | Annual General Meeting |
| 2024-04-18 09:30 am | Investor Day |
| 2024-04-08 08:00 am | Needham Virtual Healthcare Conference |
| 2024-03-25 | H.C. Wainwright Cell Therapy Virtual Conference |
| 2024-03-12 01:40 pm | Leerink Partners Global Biopharma Conference |
| 2024-03-06 08:00 am | Q4 2023 Earnings Call |
| 2024-03-06 07:00 am | Q4 2023 Earnings Release |
| 2024-03-04 10:30 am | TD Cowen Health Care Conference |
| 2024-02-08 01:30 pm | Guggenheim Healthcare Talks Biotechnology Conference |
| 2024-01-11 11:15 am | JPMorgan Healthcare Conference |
| 2023-11-08 08:00 am | Q3 2023 Earnings Call |
| 2023-11-08 07:30 am | Q3 2023 Earnings Release |
| 2023-09-27 08:35 am | Cantor Global Healthcare Conference |
| 2023-08-09 08:00 am | Q2 2023 Earnings Call |
| 2023-08-09 07:29 am | Q2 2023 Earnings Release |
| 2023-06-03 02:15 pm | American Society of Clinical Oncology Conference |
| 2023-06-02 08:00 am | Business Update Call |
| 2023-05-16 07:00 am | Annual General Meeting |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,12 1,92 -41.56% | 3,96 3,29 20.18% | 6,15 111 -94.44% | 27,1 25,5 6.63% | 60,3 86,1 -29.95% | 85,1 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | -158 -170 6.96% | -130 -81,7 -59% | -63,3 |
|
EBIT Million USD | Released Forecast Spread | -140 -145 3.77% | -133 -132 -0.96% | -162 -159 -2.04% | -164 -172 4.53% | -140 -105 -33.04% | -97,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -137 -146 6.26% | -130 -129 -0.91% | -157 -156 -0.64% | -163 -160 -2.15% | -113 -74,3 -51.53% | -92,2 |
|
Net income Million USD | Released Forecast Spread | -137 -146 6.24% | -130 -129 -0.96% | -158 -82,7 -91.16% | -165 -165 -0.41% | -114 -83,2 -36.95% | -91,1 |
|
EPS USD | Released Forecast Spread | -1,32 -1,35 2.22% | -0,90 -0,90 0.37% | -1,02 -0,52 -96.15% | -1,02 -1,07 4.67% | -0,54 -0,33 -63.64% | -0,29 |
| Announcement Date | 27/02/20 | 25/02/21 | 14/03/22 | 06/03/23 | 06/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 1,42 106 -98.66% | 3,58 5,00 -28.5% | 5,54 10,1 -45.17% | 7,01 5,00 40.14% | 11,0 5,08 116.94% | 47,6 | 5,13 6,68 -23.15% | 7,32 15,1 -51.66% | 0,23 26,0 -99.11% | 17,1 | 27,7 | 12,4 | 27,9 | 15,9 |
|
EBIT Million USD | Released Forecast Spread | -42,9 -39,6 -8.24% | -50,0 -42,5 -17.69% | -43,8 -49,0 10.71% | -43,0 -45,2 4.95% | -27,2 -42,1 35.29% | 1,66 | -44,9 -42,4 -5.83% | -46,6 -30,2 -54.26% | -49,9 -15,1 -229.3% | -28,9 | -16,0 | -34,4 | -18,2 | -32,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -38,6 -37,6 -2.79% | -49,6 -39,7 -25.02% | -44,1 -49,0 10.1% | -41,0 -38,9 -5.46% | -28,3 -38,0 25.64% | 1,66 | -20,7 -47,6 56.49% | -44,9 -29,0 -54.88% | -48,6 -10,3 -370.06% | -27,6 | -14,9 | -33,0 | -16,7 | -32,3 |
|
Net income Million USD | Released Forecast Spread | -38,9 36,5 -206.46% | -50,3 -39,8 -26.29% | -44,5 -41,4 -7.67% | -41,4 -38,9 -6.48% | -29,3 -38,0 23.03% | 1,04 | -21,4 -47,9 55.35% | -45,6 -32,0 -42.39% | -47,9 -17,2 -178.59% | -22,7 | -17,3 | -32,6 | -18,6 | -32,3 |
|
EPS USD | Released Forecast Spread | -0,24 0,25 -197.96% | -0,30 -0,25 -22.45% | -0,05 -0,26 80.77% | -0,04 -0,24 83.33% | -0,18 -0,23 20% | 0,00 -0,14 - | -0,12 -0,21 42.86% | -0,03 -0,19 83.93% | -0,24 0,00 - | -0,08 | -0,07 | -0,08 | -0,07 | -0,14 |
| Announcement Date | 14/03/22 | 09/05/22 | 04/08/22 | 08/11/22 | 06/03/23 | 12/05/23 | 09/08/23 | 08/11/23 | 06/03/24 | - | - | - | - | - |
| 2024-05-15 | BIOCON LIMITED: Q4 2024 Earnings Release |
| 2024-05-16 09:00 am | ZEALAND PHARMA A/S: Q1 2024 Earnings Release |
| 2024-05-17 07:00 am | AUTOLUS THERAPEUTICS PLC: Q1 2024 Earnings Release |
| 2024-07-23 | VIKING THERAPEUTICS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | BIOCON LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-25 01:00 am | ARGENX SE: Q2 2024 Earnings Release |
| 2024-07-29 | RHYTHM PHARMACEUTICALS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | NEUROCRINE BIOSCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-29 | CEREVEL THERAPEUTICS HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-30 | CASSAVA SCIENCES, INC.: Q2 2024 Earnings Release (Projected) |
Past sector events for Adaptimmune Therapeutics plc
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- ADAP Stock
- Calendar Adaptimmune Therapeutics plc